Building once again on their first mover position as a leader in endovascular hemorrhage control and resuscitation, Prytime ...

Prytime Medical Devices, Inc. announced a new FDA 510(k) clearance for the pREBOA-Pro catheter, the company’s flagship dev ...

Data from trials investigating the effects and risks of endovascular thrombectomy for the treatment of stroke due to basilar-artery occlusion are limited. We conducted a multicenter, prospective, ...

Faricimab is recommended, within its marketing authorisation, as an option for treating visual impairment caused by macular oedema after central or branch retinal vein occlusion in adults. It is only ...

Evidence-based recommendations on aflibercept (Eylea) for treating sight problems caused by macular oedema from central retinal vein occlusion in adults. We checked this guidance and found nothing new ...

Central retinal artery occlusion (CRAO) is considered to be an acute stroke of the eye that results in profound visual loss. Spontaneous recovery rates are poor. Most CRAOs are caused by ...